Hedgehog signaling is critical for maintenance of the adult coronary vasculature in mice

Journal of Clinical Investigation

Volumn 118, Issue 7, 2008, Pages 2404-2414

  Lavine, Kory J ^a   Kovacs, Attila ^a   Ornitz, David M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN PATCHED 1; SONIC HEDGEHOG PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAPILLARY; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY BLOOD VESSEL; GENE EXPRESSION; HEART FUNCTION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART VENTRICLE FAILURE; HOMEOSTASIS; HYPOXEMIA; LETHALITY; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; SURVIVAL;

ANGIOGENIC PROTEINS; ANIMALS; APOPTOSIS; CARDIOMEGALY; CELL SURVIVAL; CORONARY VESSELS; FIBROBLASTS; FIBROSIS; HEART; HEDGEHOG PROTEINS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MUSCLE, SMOOTH, VASCULAR; MYOCARDIAL ISCHEMIA; MYOCARDIUM; MYOCYTES, CARDIAC; RECEPTORS, CELL SURFACE; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION; VERATRUM ALKALOIDS;

EID: 46849087764     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JC134561     Document Type: Article

References (27)

1. Caines, A.E., et al. 2004. Outcomes of coronary artery bypass grafting versus percutaneous coronary intervention and medical therapy for multivessel disease with and without left ventricular dysfunction. Cardiology. 101:21-28.
2. Syed, I.S., Sanborn, T.A., and Rosengart, T.K. 2004. Therapeutic angiogenesis: a biologic bypass. Cardiology. 101:131-143.
3. Simons, M., et al. 2002. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial. Circulation. 105:788-793.
4. Losordo, D.W., et al. 2002. Phase 1/2 placebo-controlled, double-blind, dose-escalating trial of myocardial vascular endothelial growth factor 2 gene transfer by catheter delivery in patients with chronic myocardial ischemia. Circulation. 105:2012-2018.
5. Henry, G.D., et al. 2000. Intracavernosal injections of vascular endothelial growth factor protects endothelial dependent corpora cavernosal smooth muscle relaxation in the hypercholesterolemic rabbit: a preliminary study. Int. J. Impot. Res. 12:334-339.
6. Kusano, K.F., et al. 2005. Sonic hedgehog myocardial gene therapy: tissue repair through transient reconstitution of embryonic signaling. Nat. Med. 11:1197-1204.
7. Lavine, K.J., et al. 2006. Fibroblast growth factor signals regulate a wave of Hedgehog activation that is essential for coronary vascular development. Genes Dev. 20:1651-1661.
8. Goodrich, L.V., Milenkovic, L., Higgins, K.M., and Scott, M.P. 1997. Altered neural cell fates and medulloblastoma in mouse patched mutants. Science. 277:1109-1113.
9. Pearse, R.V., 2nd, Vogan, K.J., and Tabin, C.J. 2001. Ptc1 and Ptc2 transcripts provide distinct readouts of Hedgehog signaling activity during chick embryogenesis. Dev. Biol. 239:15-29.
10. Long, F., Zhang, X.M., Karp, S., Yang, Y., and McMahon, A.P. 2001. Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation. Development. 128:5099-5108.
11. Sohal, D.S., et al. 2001. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ. Res. 89:20-25.
12. Gerety, S.S., Wang, H.U., Chen, Z.F., and Anderson, D.J. 1999. Symmetrical mutant phenotypes of the receptor EphB4 and its specific transmembrane ligand ephrin-B2 in cardiovascular development. Mol. Cell. 4:403-414.
13. Wang, H.U., Chen, Z.F., and Anderson, D.J. 1998. Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor Eph-B4. Cell. 93:741-753.
14. Kennedy, A.S., et al. 1997. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: first report of combined immunohistochemical assays. Int. J. Radiat. Oncol. Biol. Phys. 37:897-905.
15. Ward, N.L., and Dumont, D.J. 2002. The angiopoietins and Tie2/Tek: adding to the complexity of cardiovascular development. Semin. Cell Dev. Biol. 13:19-27.
16. Visconti, R.P., Richardson, C.D., and Sato, T.N. 2002. Orchestration of angiogenesis and arteriovenous contribution by angiopoietins and vascular endothelial growth factor (VEGF). Proc. Natl. Acad. Sci. U. S. A. 99:8219-8224.
17. Lawson, N.D., et al. 2001. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development. 128:3675-3683.
18. Sanchez, P., Clement, V., and Ruiz i Altaba, A. 2005. Therapeutic targeting of the Hedgehog-GLI pathway in prostate cancer. Cancer Res. 65:2990-2992.
19. Williams, J.A. 2003. Hedgehog signaling pathway as a target for therapeutic intervention in basal cell carcinoma. Drug News Perspect. 16:657-662.
20. Williams, J.A., et al. 2003. Identification of a small molecule inhibitor of the hedgehog signaling pathway: effects on basal cell carcinoma-like lesions. Proc. Natl. Acad. Sci. U. S. A. 100:4616-4621.
21. Sanchez, P., and Ruiz i Altaba, A. 2005. In vivo inhibition of endogenous brain tumors through systemic interference of Hedgehog signaling in mice. Mech. Dev. 122:223-230.
22. Romer, J.T., et al. 2004. Suppression of the Shh pathway using a small molecule inhibitor eliminates medulloblastoma in Ptc1(+/-)p53(-/-) mice. Cancer Cell. 6:229-240.
23. Berman, D.M., et al. 2002. Medulloblastoma growth inhibition by hedgehog pathway blockade. Science. 297:1559-1561.
24. Wunder, J.S., Nielsen, T.O., Maki, R.G., O'Sullivan, B., and Alman, B.A. 2007. Opportunities for improving the therapeutic ratio for patients with sarcoma. Lancet Oncol. 8:513-524.
25. Feldmann, G., et al. 2007. Blockade of hedgehog signaling inhibits pancreatic cancer invasion and metastases: a new paradigm for combination therapy in solid cancers. Cancer Res. 67:2187-2196.
26. Soriano, P. 1999. Generalized lacZ expression with the ROSA26 Cre reporter strain. Nat. Genet. 21:70-71.
27. Ren, J., Zhang, S., Kovacs, A., Wang, Y., and Muslin, A.J. 2005. Role of p38alpha MAPK in cardiac apoptosis and remodeling after myocardial infarction. J. Mol. Cell. Cardiol. 38:617-623.